| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |